Jazz Pharma to pay $145 million to settle narcolepsy drug antitrust case Reuters Apr 9, 2025 Settlement resolves allegations Jazz delayed generic Xyrem launch, driving up costs for health plans and patients
Hikma Pharma launches Xyrem’s generic in US EP News Bureau Jan 4, 2023 The company will have 180 days of marketing exclusivity for its authorised generic product in the US
